NUZ-001, an investigational oral therapy for ALS, is officially the ninth compound to be included in the HEALEY ALS platform ...

The close of the brief wreath-making season reminds columnist Kristin Neva how much different it is than being a long-term ...

The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...

Qalsody is one step closer to being covered by public Canadian healthcare systems when used to treat adults with ALS with ...

Researchers have developed a novel approach to detect ALS and predict survival by measuring genetic activity in blood cells, a study found.

AMX0114, an experimental ALS medication, showed safety and was well tolerated in initial trial participants. The drug aims to reduce calpain-2, an enzyme linked to nerve fiber degeneration in ALS. The ...

A bipartisan team of congressional representatives is pushing for new legislation that aims to understand why veterans are at increased… ...